PDA Announces 2004 Board of Directors and Officers

Strategic Insights -

PDA, a leading international association for pharmaceutical and biopharmaceutical science and technology, has announced its 2004 Board of Directors and Officers. The highly-qualified group of senior executives brings a rich and diverse skill set to the association, with representation from Europe, the Pacific Rim, and the Americas. The 2004 Board is composed of seasoned professionals from large corporations, early stage companies, independent consulting services, and international health authorities. This group will provide strong leadership to PDA, ensuring the association remains the authoritative voice and leading technical organization dedicated to promoting scientifically sound and practical technical information and education worldwide.

Key Takeaways:

  • The 2004 PDA Board of Directors and Officers consists of a highly-qualified group of senior executives with a rich and diverse skill set.
  • The Board brings together seasoned professionals from large corporations, early stage companies, independent consulting services, and international health authorities.
  • The 2004 Board is representative of a broad global base, with members located in Europe, the Pacific Rim, and the Americas.
  • PDA's 2004 Board will provide strong guidance to the association, ensuring it remains the authoritative voice and leading technical organization in the fields of pharmaceutical and biopharmaceutical science and technology.
  • The Board will focus on promoting scientifically sound and practical technical information and education for industry and regulatory agencies worldwide.
  • PDA has a membership of over 10,000 individual scientists involved in the development, manufacture, quality control, and regulation of pharmaceuticals and related products.
  • Neal Koller, PDA President, emphasized the importance of the 2004 Board's diverse skill set in providing strong leadership to the association.

Statistics:

  • PDA has a membership of over 10,000 individual scientists involved in the development, manufacture, quality control, and regulation of pharmaceuticals and related products.
  • The 2004 PDA Board is composed of senior executives with a rich and diverse skill set, bringing together experience from large corporations, early stage companies, independent consulting services, and international health authorities.

Sources:

  • PRNewswire, "PDA Announces 2004 Board of Directors and Officers" (January 6)